Abbott Laboratories (SWX:ABT)
Switzerland · Delayed Price · Currency is CHF 99.00
0.00 (0.00%)
At close: Dec 19, 2025
Abbott Laboratories Market Cap
Abbott Laboratories has a market cap or net worth of 173.53 billion as of December 19, 2025. Its market cap has decreased by -2.32% in one year.
Market Cap
173.53B
Enterprise Value
177.94B
Revenue
34.96B
Ranking
n/a
PE Ratio
15.63
Stock Price
99.00
Market Cap Chart
Since January 2, 1968, Abbott Laboratories's market cap has increased from 636.28M to 173.53B, an increase of 27,171.83%. That is a compound annual growth rate of 10.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 173.53B | -2.39% |
| Dec 31, 2024 | 177.78B | 10.48% |
| Dec 29, 2023 | 160.91B | -9.10% |
| Dec 30, 2022 | 177.01B | -19.55% |
| Dec 31, 2021 | 220.03B | 32.56% |
| Dec 31, 2020 | 165.98B | 11.57% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 278.18B |
| Novartis AG | 208.23B |
| Galderma Group AG | 38.65B |
| Lonza Group AG | 37.42B |
| Alcon | 31.21B |
| Sandoz Group AG | 24.95B |
| Straumann Holding AG | 15.03B |
| Sonova Holding AG | 12.29B |